NASDAQ:FGEN Long Term Investor Notice: Lawsuit Filed Against Certain Directors of FibroGen, Inc
An investor in FibroGen, Inc. (NASDAQ:FGEN) shares filed a lawsuit against certain directors of FibroGen, Inc over alleged breaches of fiduciary duties.
View full press release